Articles by Bikash Chatterjee - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by Bikash Chatterjee

The Challenges of Emerging Markets

The difficulties of doing business in China are offset by its adoption of more stringent GMP standards. Part of a special outsourcing section.
Feb 1, 2012

The difficulties of doing business in China are offset by its adoption of more stringent GMP standards.

Integrating Risk Management as an Effective Approach to Root Cause Analysis

Optimize time and cost of product development by managing risk.
Jan 1, 2009

Optimize time and cost of product development by managing risk.

Preparedness for Pandemic Flu Outbreak

Biopharmaceutical companies should come together to create an efficient business continuity plan that would be effective in a pandemic.
Oct 2, 2008

To succeed in a pandemic, the industry must forge a preparedness plan to ensure adequate vaccines.

Final Word: Outsourcing in Today's Risk-Based Environment

As the sophistication of products continues to grow, so do the risks associated with choosing the right partner
Jun 1, 2007

Outsourcing has been a cornerstone of our industry for decades.

Pursuing Pharmaceutical Quality and Economy

Forward-looking pharmaceutical companies build continuous improvement techniques into their processes from day one.
Jun 1, 2006

Motorola recognized that vartion is the death knell of any process, so the company established a methodology called Six Sigma

ADVERTISEMENT

ADVERTISEMENT

Click here